Rating History for Compass Therapeutics (CMPX) by Raymond James

More Stocks Rated by Raymond James | Latest Ratings for CMPX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
4/28/2026 Sean McCutcheon Downgrade Market Perform
(Outperform)		 N/A
(N/A)		 1.79
(2.02)		 12.85% Details